[ESPR] YoY Quarter Result on 30-Jun-2014 [#Q2]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
12-Aug-2014
Financial Year
2014
Quarter
30-Jun-2014 [#Q2]
Profit Trend
QoQ- -17.32%
YoY- -33.48%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/03 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -43,337 -14,035 -12,395 -9,238 -6,921 -3,166 -8,435 12.39%
Tax 433 494 337 18 112 304 922 -5.25%
NP -43,337 -14,035 -12,395 -9,238 -6,921 -3,166 -8,435 12.39%
Tax Rate - - - - - - - -
Total Cost 43,337 14,035 12,395 9,238 6,921 3,166 8,435 12.39%
Ratio Analysis
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/03 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/03 CAGR
EPS -1.92 -0.62 -0.55 -0.60 -0.47 -0.33 -2.00 -0.29%
EPS Diluted -1.92 -0.62 -0.55 -0.60 -0.47 -0.33 -2.00 -0.29%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.